Skip to main content

Peer Review reports

From: Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy

Original Submission
3 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Mar 2022 Reviewed Reviewer Report
28 Mar 2022 Reviewed Reviewer Report
6 Apr 2022 Reviewed Reviewer Report
14 May 2022 Author responded Author comments - Amanda Lusa
Resubmission - Version 3
14 May 2022 Submitted Manuscript version 3
18 May 2022 Author responded Author comments - Amanda Lusa
Resubmission - Version 4
18 May 2022 Submitted Manuscript version 4
19 May 2022 Author responded Author comments - Amanda Lusa
Resubmission - Version 5
19 May 2022 Submitted Manuscript version 5
1 Jun 2022 Reviewed Reviewer Report
1 Jun 2022 Reviewed Reviewer Report
7 Jun 2022 Reviewed Reviewer Report
21 Jun 2022 Author responded Author comments - Amanda Lusa
Resubmission - Version 6
21 Jun 2022 Submitted Manuscript version 6
22 Jun 2022 Author responded Author comments - Amanda Lusa
Resubmission - Version 7
22 Jun 2022 Submitted Manuscript version 7
30 Jun 2022 Reviewed Reviewer Report
1 Jul 2022 Reviewed Reviewer Report
17 Jul 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
20 Jul 2022 Editorially accepted
8 Nov 2022 Article published 10.1186/s41927-022-00297-5

You can find further information about peer review here.

Back to article page